Eleven Therapeutics vs Moderna
Eleven Therapeutics vs Moderna, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Eleven Therapeutics is on 56/100 and Moderna on 77/100.
Where each one leads
Eleven Therapeutics
Leads on none of the measures we hold for both companies.
Moderna
- our overall score: 77/100 against 56/100
- agent readiness: 49/100 against 40/100
- domain rating: 79/100 against 13/100
- headcount: 6,297 against 28
- funding raised: $4.5B against $22.0M
- LinkedIn following: 780,086 against 5,528
At a glance
| Measure | Eleven Therapeutics | Moderna |
|---|---|---|
| What it is | Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases. | Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics. |
| Category | Healthcare, Life Sciences, Therapeutics, Biotech | Biotechnology, mRNA Technology, Vaccines, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2017 | 2010 |
| Headquarters | London, United Kingdom | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Eleven Therapeutics | Moderna |
|---|---|---|
| Employees | 28 | 6,297 |
| Headcount growthLast 12 months | +17.6% | Not published |
| Open roles | 4 | 100 |
| Total funding | $22.0M | $4.5B |
| Latest round | Seed | Funding Round |
| LinkedIn followers | 5,528 | 780,086 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Eleven Therapeutics | Moderna |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 77/100 |
| Traction | 51/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Community | Not published | 13/100 |
| Search visibility | 30/100 | 46/100 |
| Quality | 58/100 | 90/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | D (49/100) |
| Domain ratingLink authority, 0-100 | 13/100 | 79/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Eleven Therapeutics | Moderna |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Cloudflare | CloudFront |
| CMS | Webflow | Not detected |
| Frameworks | Not detected | Next.js |
What users say
| Measure | Eleven Therapeutics | Moderna |
|---|---|---|
| Community ratingVisitor votes on StartupHub | Not published | 2.0/5 from 1 vote |
Eleven Therapeutics vs Moderna: common questions
Which is better, Eleven Therapeutics or Moderna?
On our 0-100 score Moderna rates higher (77/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Eleven Therapeutics and Moderna compare on the numbers?
Moderna leads on our overall score (77/100 against 56/100), agent readiness (49/100 against 40/100), domain rating (79/100 against 13/100), headcount (6,297 against 28), funding raised ($4.5B against $22.0M), LinkedIn following (780,086 against 5,528).
Read the full Eleven Therapeutics review and pricing or the Moderna review and pricing. You can also browse other Eleven Therapeutics alternatives we track.